Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, September 2000, p. 2419-2423, Vol. 44, No. 9
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Effect of Metronidazole on the Pathogenicity of
Resistant Bacteroides Strains in Gnotobiotic Mice
Claudio Galuppo
Diniz,1
Denise Carmona
Cara,2
Jacques Robert
Nicoli,1
Luiz De Macedo
Farias,1 and
Maria
Auxiliadora Roque
De
Carvalho1,*
Departamento de
Microbiologia1 and Departamento de
Patologia Geral,2 ICB-UFMG, 30.161-970 Belo
Horizonte, MG, Brazil
Received 31 January 2000/Returned for modification 31 March
2000/Accepted 7 June 2000
 |
ABSTRACT |
Metronidazole is widely used to treat protozoan and fungal
infections. As an antibacterial drug, it is used mainly against anaerobes. Among anaerobes, the Bacteroides fragilis group
is the most relevant in terms of frequency of recovery and
antimicrobial resistance patterns. The use of metronidazole and other
antimicrobial drugs induces morphological changes in this bacterial
group. The present study investigated in vivo if these morphological
modifications were accompanied by changes in virulence patterns by
using germfree mice experimentally challenged with
metronidazole-resistant Bacteroides strains before and
after exposure to metronidazole. It was observed that
metronidazole-resistant strains were more virulent after contact with
the drug, as demonstrated by anatomicopathologic data for spleen,
liver, and small intestine samples. These results suggest that
long-term therapy and high metronidazole concentrations could interfere
with microbial pathogenicity, resulting in changes to host-bacterium relationships.
 |
INTRODUCTION |
Anaerobic bacteria are an
evolutionarily and ecologically significant group. Their ability to
survive under diverse conditions and versatility give them the status
of amphibiotic organisms (9). Species of the
Bacteroides fragilis group emerge as the predominant
microorganisms in the normal microbiota of humans and other mammals and
constitute one-third of the pathogens isolated from anaerobic
infections. These infections are characterized mainly by
intra-abdominal and pulmonary abscesses and other kinds of infections,
including septicemia (9). The bacteria's virulence has
mainly been related to cell surface compounds, such as the outer
capsular polysaccharide envelope and outer membrane lipopolysaccharide, as well as to the production of hydrolytic enzymes and exotoxin (22).
Nowadays, metronidazole (2-methyl-5-nitroimidazole-1-ethanol) is widely
used to treat protozoan diseases and against mainly anaerobic bacteria,
including Bacteroides (10). Under anaerobic conditions, 5-nitroimidazoles are reduced to cytotoxic nitroradicals, which have been shown to act by inactivating DNA and other cell components (5).
Since 1940, many authors have observed that gram-positive rods exposed
to low concentrations of penicillin and other antimicrobial agents show
altered morphology indicative of aberrant bacterial cells
(11). Later it was demonstrated that such aberrant cells could also occur among treated gram-negative bacteria and yeasts (16, 19). In the B. fragilis group, the
occurrence of aberrant cell shape caused by previous treatment with low
or high concentrations of antimicrobial drugs such as metronidazole has
been also described as indicative of altered cellular properties
(4, 24). It has been suggested that these changes in cell
shape could lead to eventual differences in the virulence properties of
microorganisms and in their relationships with host immunodefenses
(16).
The objective of the present study was to investigate in vivo
whether previous treatment with high concentrations of
metronidazole may be capable of inducing any change in the
virulence profile of metronidazole-resistant Bacteroides
cells isolated from human clinical specimens and from the
gastrointestinal tracts of healthy marmosets, using germfree mice as a
study model.
 |
MATERIALS AND METHODS |
Bacterial strains.
Two metronidazole-resistant strains
identified with the API 20A kit (BioMérieux S.A., Marcy
l'Etoile, France) as Bacteroides distasonis were used. One
of them was isolated from a human intra-abdominal abscess (RH), and the
other was isolated from the gastrointestinal tract of a healthy
marmoset (Callithrix penicillata) (RM). Both of them were
metronidazole resistant (the MIC at which 90% of the isolates tested
were inhibited was 256 µg/ml for RH and 512 µg/ml for RM) according
to the agar dilution test and were stored at
86°C in our culture
collection. They were divided into four groups distinguished by
maintenance in the presence of (RHmzol and
RMmzol) or absence (RH and RM) of metronidazole. The
strains were grown in 5 ml of brain heart infusion supplemented with
hemin, menadione, and yeast extract (BHI-S), either containing or not containing 200 µg of metronidazole (lot no. 54H0407; Sigma Chemical Company, St. Louis, Mo.)/ml. The bacteria were grown for 24 h at
37°C in an anaerobic chamber (Forma Scientific Inc., Marietta, Ohio)
containing an atmosphere of 85% N2, 10% H2,
and 5% CO2.
Animals.
Germfree NIH (Taconic, Germantown, N.Y.) 21-day-old
mice were used in this study. The animals were housed in flexible
plastic isolators (Standard Safety Company, Palatine, Ill.) and were
handled according to established procedures (20). The
animals were fed an autoclavable commercial diet for rodents (Nuvital,
Curitiba, Brazil). Experiments with gnotobiotic mice were carried out
in microisolators (UNO Roestvastaal B.V., Zevenaar, The Netherlands).
Experimental challenge.
Thirty germfree mice were divided
into five experimental groups of six animals. Each group was designated
as follows, according to the associated bacterial strain: group 1, RHmzol, group 2, RH; group 3, RMmzol, group 4, RM; and group 5, control germfree. The groups were inoculated
intragastrically with 0.1 ml of anaerobically grown (for 24 h)
suspensions in BHI-S of RHmzol, RMmzol, RH, and RM which contained about 108 CFU/ml.
Microbial counts in gnotobiotic groups.
Feces collected by
anal stimulation from all mice every 72 h after the challenge were
introduced into the anaerobic chamber, diluted 100-fold in regenerated
sterile buffered saline (pH 7.4), and homogenized by hand. Serial
10-fold dilutions were obtained, and 0.1-ml amounts were plated onto
BHI agar supplemented with hemin, menadione, and yeast extract (BHI
agar-S). The petri dishes were incubated for 48 h in the anaerobic
chamber at 37°C, after which colonies were counted. The monoxenic
(groups 1, 2, 3, and 4) or germfree (group 5) status of the animals was
regularly tested, and metronidazole resistance was reevaluated after
recovering the Bacteroides strains from mouse feces (BHI
agar-S containing 200 µg of metronidazole/ml).
Histopathologic evaluation.
All experimental and control
animals were sacrificed by ether inhalation and necropsied after 14 days of infection. Spleen, liver, and small intestine samples were
excised and evaluated macroscopically. Small intestine samples were
identified as duodenum, proximal jejunum, distal jejunum, and ileum
according to established procedures (7). Fragments of
spleen, liver, and small intestine were fixed in
formaldehyde-phosphate-buffered saline (1:10, pH 7.2) and dehydrated
in alcoholic solution by using an automated tissue processor (Titertek
Autotechnicon, Technicon tissue processor no. 2A; The Technicon
Company, Chauncey, N.Y.). The fragments were embedded in paraffin, and
4-µm cross sections were obtained with a microtome (no. 820; Spencer,
Buffalo, N.Y.). The slides were stained with hematoxylin and eosin,
coded, and examined by a single pathologist, who was unaware of the
experimental conditions for each group.
Statistical analysis.
Some data were evaluated by analysis
of variance. Statistical analysis was performed with EPISTAT software
(T. L. Gustafson, Round Rock, Tex.), with the level of
significance set at a value of P < 0.05.
 |
RESULTS |
We observed that during and after metronidazole exposure, the
samples (RHmzol and RMmzol) showed altered
morphology with filamentous cell formation (Fig.
1).

View larger version (124K):
[in this window]
[in a new window]
|
FIG. 1.
Gram stain of B. distasonis cells before and
after metronidazole exposure. (A) Human (left) and marmoset (right)
strains before drug exposure; (B) Human (left) and marmoset (right)
strains after metronidazole maintenance (200 µg/ml). Original
magnification, ×1,000.
|
|
Figure 2 shows that the
Bacteroides strains became established in the digestive
tracts of all experimental gnotobiotic groups and that the number of
CFU was about 109/g of feces.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 2.
Bacterial population levels in the feces of germfree NIH
mice intragastrically challenged with B. distasonis strains
previously treated (RHmzol and RMmzol) or not
(RH and RM) with metronidazole.
|
|
The macroscopic examination of livers from animals infected with all
the Bacteroides strains did not show any apparent
alteration. Spleens from mice infected with the RHmzol
strain proved to be seriously damaged. Significant atrophy was observed
when they were compared with spleens from animals infected with
RMmzol, RH, and RM and from the control group (Fig.
3). Analysis of variance of the spleen
areas showed that this atrophy was statistically significant
(P < 0.05). Macroscopic examination of the small
intestine showed hemorrhagic areas in the duodenum and proximal
jejunum.

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 3.
Mean areas of the spleens from germfree (control) and
gnotobiotic mice infected for 14 days with B. distasonis
strains previously treated (RHmzol and RMmzol)
or not (RH and RM) with metronidazole. Different letters above bars
indicate that results were significantly different (P < 0.05).
|
|
Histopathologic examination of spleen, liver, and intestine samples
confirmed the macroscopic data, showing significant lesions in the
animals infected with the RHmzol and RMmzol
strains. Lesions or alterations were not observed in the group infected
with the RH and RM strains or in the control group. The intestinal
lesions were markedly expressed as altered villi with erythrocytes in the mucous tissue and congested blood vessels (Fig.
4). These lesions, however, were more
evident in the animals infected with the RHmzol strain.
Microscopically, livers from animals infected with RHmzol
and RMmzol showed some hemorrhagic areas with congested blood vessels. The same was not observed in the animals infected with
the RH and RM strains or in the control group. In spleens from mice
infected with the RHmzol strain, a reduction of the lymphoid component and red pulp was observed when those spleens were compared with spleens from animals infected with
RMmzol, RH, and RM and from the control group (Fig.
5).

View larger version (72K):
[in this window]
[in a new window]
|
FIG. 4.
Histological examination of small intestine mucosae from
gnotobiotic mice infected for 14 days with resistant B. distasonis strains not treated (RH [A]) or previously treated
(RHmzol [B]) with metronidazole. White arrows show the
appearance of blood vessels (normal [A] and congested [B]). Black
arrows (B) indicate mucosal hyperhemia, showing blood cells at the
basal mucosa of intestine from an animal challenged with
RHmzol. Interestingly, strain RMmzol behaved
very similarly to RHmzol. Hematoxylin and eosin were
applied. Original magnification, ×240.
|
|

View larger version (128K):
[in this window]
[in a new window]
|
FIG. 5.
Histological examination of the spleen from gnotobiotic
mice infected for 14 days with B. distasonis strains
previously treated (RHmzol [A] and RMmzol
[B]) or not (RH [C] and RM [D]) with metronidazole. Dark areas on
photomicrographs indicate red pulp, and light areas indicate white
pulp. Hematoxylin and eosin were applied. Original magnification,
×46.
|
|
 |
DISCUSSION |
There is a delicate balance in the intestine among the number of
microbes and their virulence characteristics and the immune status of
the host. Infection occurs whenever a microbe, whether by exposing the
host to a larger infective dose or by increasing its own virulence
characteristics, manages to disrupt the balance in its favor. Many of
the bacteria in the gastrointestinal ecosystem, especially
gram-negative rods, are opportunistic pathogens and are capable of
eliciting injurious, proinflammatory responses if viable bacteria or
soluble cell surface components or metabolic products interact with
cells of the immune system (12). This indigenous microbiota
may be pathogenic during an eventual disequilibrium of the digestive
ecosystem or when these microorganisms are introduced into sterile
areas of the body (3, 25). This disequilibrium may be due to
immunosuppression, infectious or noninfectious diseases, or long-term
therapy with antimicrobial agents.
Virulence factors may vary among individuals in the same microbial
population. Thus, any agent that can interfere with their genetic
profiles may influence the initial virulence properties of this
population (16). In the B. fragilis group, the
virulence has mainly been related to capsular polysaccharide,
lipopolysaccharide, hydrolytic enzymes, and exotoxin (22).
Various studies have indicated that short-chain fatty acids are also
important virulence factors which affect the host defense mechanisms.
Butyric acid, in particular, inhibits T-cell proliferation induced by
different mitogenic stimuli (13).
Since the early 1940s many authors have observed morphological changes
in various microbial species in the presence of different antimicrobial
agents. In almost all cases these alterations are related to
differences in the virulence patterns of such microorganisms (8,
11, 15, 23). In various studies, elongated cells of B. fragilis were observed in the presence of metronidazole, as was
the case with B. distasonis strains during and after
metronidazole exposure in this study. Elongation appears to result from
the inhibition of autolytic enzymes that initiate separation.
Nevertheless, the extent and consequences of these aberrant forms for
the virulence properties of the B. fragilis group are unclear.
It has been previously demonstrated that antimicrobial agents are
capable of interfering with the adhesiveness and enzyme and toxin
production of different microbial groups. The
-lactams, quinolones,
tetracyclines, glycopeptides, macrolides, lincosamides, and
nitroimidazoles may stimulate adhesiveness to both epithelial and
intestinal cells and the production of hemolysin, penicillinases, enterotoxins, other toxins, and enzymes by different species, such as
Staphylococcus aureus, Streptococcus pyogenes,
Streptococcus pneumoniae, Escherichia coli,
Vibrio cholerae, Clostridium difficile, and
B. fragilis (8, 14, 15, 17, 21, 26, 27). The enhancement of surface anionogenicity and hydrophobicity of
Bacteroides by metronidazole, as an example, may allow the
bacteria to approach negatively charged surfaces of animal cells more efficiently.
In this study, the metronidazole-resistant strains showed differences
in host-microbial interaction after exposure to metronidazole. RHmzol and RMmzol were more pathogenic, as
shown by the histopathologic data. However, RHmzol was more
virulent and had an unexpected and strong effect on the spleen in
particular, which atrophied during the infection. It is well
established that red pulp may function as a blood reserve. The atrophy
of this spleen component may be related to hemorrhagic processes like
that observed in the intestines of animals challenged with
metronidazole-resistant strains maintained in the presence of this
drug. On the other hand, white pulp is comprised of lymphnodes and
should grow during the acute immune response. However, during
immunosuppression, these lymphnodes generally undergo degeneration by
cellular apoptosis, which causes a reduction in the size of most
lymphoid organs (mainly the spleen) (2). This pattern also
establishes the interference of anaerobic bacteria with the host's
immune response, acting as lymphocyte suppressor agents (6).
The present results suggest that antibiotic resistance in
microorganisms leads to an increase in morbidity and mortality not only
by increasing the risk of inappropriate therapy but also by
simultaneously increasing the virulence of such resistant
microorganisms. Further prospective clinical, pathological, and
immunological investigations are needed to elucidate the level of
interference of metronidazole and other antimicrobial agents, mainly in
the remaining susceptible and indigenous microorganisms, as established by the American Society for Microbiology (1) and by the
European Societies of Health (18).
 |
ACKNOWLEDGMENTS |
We are grateful to Wanderlany Amâncio Martins, Rinaldo
Duarte, and Andréia Marçal da Silva for their help in the
experiments with germfree animals and to Francisco José Neves
Júnior, Luzia Rosa Rezende, and Maria Gorete Barbosa Ribas for
technical help.
We thank CNPq and FAPEMIG for infrastructure and research fellowships.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Departamento de
Microbiologia, ICB-UFMG, Caixa Postal 486, 30.161-970 Belo Horizonte, MG, Brazil. Phone: 55.31.499.27.61. Fax: 55.31.499.27.30. E-mail: marc{at}mono.icb.ufmg.br.
 |
REFERENCES |
| 1.
|
ASM Task Force on Antibiotic Resistance.
1995.
Report of the ASM Task Force on Antibiotic Resistance.
American Society for Microbiology, Washington, D.C.
|
| 2.
|
Barret, J. T.
1978.
An introduction to immunochemistry and immunobiology, 3rd ed.
The C. V. Mosby Company, St. Louis, Mo.
|
| 3.
|
Broock, T. D.
1986.
Principles of microbial ecology.
Prentice-Hall, Inc., Englewood Cliffs, N.J.
|
| 4.
|
Cavalcanti, S. M. B.,
R. M. C. P. Domingues,
M. C. S. Ferreira, and F. Costa e Silva, Jr.
1991.
Effect of metronidazole on surface properties of Bacteroides fragilis.
J. Antimicrob. Chemother.
28:819-826[Abstract/Free Full Text].
|
| 5.
|
Edwards, D. I.
1993.
Nitroimidazole drugs action and resistance mechanisms. I. Mechanism of action.
J. Antimicrob. Chemother.
31:9-20[Free Full Text].
|
| 6.
|
Eftimiadi, C.,
P. Stashenko,
M. Tonetti,
P. E. Mangiante,
R. Massara,
S. Zupo, and M. Ferrarini.
1991.
Divergent effect of the anaerobic bacteria by-product butyric acid on the immune response: suppression of T-lymphocyte proliferation and stimulation of interleukin-1 beta production.
Oral Microbiol. Immunol.
6:17-23[Medline].
|
| 7.
|
Ferraris, R. P.,
S. A. Villenas, and J. Diamond.
1992.
Regulation of brush-border enzyme activities and enterocyte migration rates in mouse small intestine.
Am. J. Physiol.
262:G1047-G1059[Abstract/Free Full Text].
|
| 8.
|
Ferreira, M. C.,
M. C. P. Domingues, and M. de Uzeda.
1989.
Influence of metronidazole, chloramphenicol, clindamycin and penicillin G on growth and neuraminidase activity of Bacteroides fragilis.
J. Antimicrob. Chemother.
24:157-164[Abstract/Free Full Text].
|
| 9.
|
Finegold, S. M.
1990.
Anaerobes: problems and controversies in bacteriology, infections and susceptibility testing.
Rev. Infect. Dis.
12:223-230[Medline].
|
| 10.
|
Freeman, C. D.,
N. E. Klutman, and K. C. Lamp.
1997.
Metronidazole: a therapeutic review and update.
Drugs
54:679-708[Medline].
|
| 11.
|
Giesbrecht, P.,
T. Kersten,
H. Maidhof, and J. Wecke.
1998.
Staphylococcal cell wall: morphogenesis and fatal variations in the presence of penicillin.
Microbiol. Mol. Biol. Rev.
62:1371-1414[Abstract/Free Full Text].
|
| 12.
|
Hooper, I. V.,
I. Bry,
P. G. Falk, and J. I. Gordon.
1998.
Host-microbial symbiosis in the mammalian intestine: exploring an internal ecosystem.
Bioessays
20:236-243.
|
| 13.
|
Kyner, D.,
P. Zabos,
J. Christman, and G. Acs.
1976.
Effect of sodium butyrate on lymphocyte activation.
J. Exp. Med.
144:1674-1678[Abstract/Free Full Text].
|
| 14.
|
Levner, M.,
F. P. Wiener, and B. A. Rubin.
1977.
Induction of Escherichia coli and Vibrio cholerae enterotoxins by an inhibitor of protein synthesis.
Infect. Immun.
15:132-137[Abstract/Free Full Text].
|
| 15.
|
Lorian, V.
1971.
Effect of antibiotics on staphylococcal hemolysin production.
Appl. Microbiol.
22:106-109[Medline].
|
| 16.
|
Lorian, V., and C. G. Gemmell.
1994.
Effect of low antibiotic concentrations on bacteria: effects on ultrastructure, virulence, and susceptibility to immune defenses, p. 493-549.
In
V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., Baltimore, Md.
|
| 17.
|
Lorian, V.,
A. Waluschka, and Y. Kim.
1982.
Abnormal morphology of bacteria in the sputa of patients treated with antibiotics.
J. Clin. Microbiol.
16:382-386[Abstract/Free Full Text].
|
| 18.
|
Monnet, D. L.
1999.
European recommendations to respond to the threat of antimicrobial-resistant microorganisms.
ASM News
65:390-391.
|
| 19.
|
Nosanchuk, J. D.,
W. Cleare,
S. P. Franzot, and A. Casadevall.
1999.
Amphotericin B and fluconazole affect cellular charge, macrophage phagocytosis, and cellular morphology of Cryptococcus neoformans at subinhibitory concentrations.
Antimicrob. Agents Chemother.
43:233-239[Abstract/Free Full Text].
|
| 20.
|
Pleasants, J. R.
1974.
Gnotobiotics, p. 119-174.
In
E. C. Melby, Jr., and N. H. Altmann (ed.), Handbook of laboratory animal science. CRC Press, Cleveland, Ohio.
|
| 21.
|
Proctor, R. A.,
P. J. Olbrantz, and D. F. Mosher.
1983.
Subinhibitory concentrations of antibiotics alter fibronectin binding to Staphylococcus aureus.
Antimicrob. Agents Chemother.
24:823-826[Abstract/Free Full Text].
|
| 22.
|
Rokosz, A., and F. Meisel-Mikolajczyk.
1995.
Selected properties of Bacteroides fragilis enterotoxigenic strains.
Med. Dosw. Mikrobiol.
47:183-188[Medline]. (In Polish.)
|
| 23.
|
Settle, C. D., and M. H. Wilcox.
1996.
Review article: antibiotic-induced Clostridium difficile infection.
Aliment. Pharmacol. Ther.
10:835-841[CrossRef][Medline].
|
| 24.
|
Takahata, M., and T. Nishino.
1997.
Antibacterial activities of tosufloxacin against anaerobic bacteria and the electron micrograph of its bactericidal effects.
Chemotherapy
43:153-158[Medline].
|
| 25.
|
Tannock, G. W.
1988.
The normal microflora: new concepts in health promotion.
Microbiol. Sci.
5:4-8[Medline].
|
| 26.
|
Vosbeck, V.
1982.
Effects of low concentrations of antibiotics on Escherichia coli adhesion, p. 183-192.
In
H. U. Eickenberg, H. Hahn, and W. Opferkuch (ed.), The influence of antibiotics on the host-parasite relationship. Springer-Verlag, New York, N.Y.
|
| 27.
|
Yoh, M.,
K. Yamamoto,
T. Honda,
Y. Takeda, and T. Miwatani.
1983.
Effects of lincomycin and tetracycline on production and properties of enterotoxins of enterotoxigenic Escherichia coli.
Infect. Immun.
42:778-782[Abstract/Free Full Text].
|
Antimicrobial Agents and Chemotherapy, September 2000, p. 2419-2423, Vol. 44, No. 9
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Santos, S. G., Diniz, C. G., Silva, V. L., Martins, W. A., Cara, D. C., Souza, N. C., Serufo, J. C., Nicoli, J. R., Carvalho, M. A. R., Farias, L. M.
(2007). Effects of oxidative stress on the virulence profile of Prevotella intermedia during experimental infection in gnotobiotic mice. J Med Microbiol
56: 289-297
[Abstract]
[Full Text]
-
Diniz, C. G., Farias, L. M., Carvalho, M. A. R., Rocha, E. R., Smith, C. J.
(2004). Differential gene expression in a Bacteroides fragilis metronidazole-resistant mutant. J Antimicrob Chemother
54: 100-108
[Abstract]
[Full Text]
-
Gal, M., Brazier, J. S.
(2004). Metronidazole resistance in Bacteroides spp. carrying nim genes and the selection of slow-growing metronidazole-resistant mutants. J Antimicrob Chemother
54: 109-116
[Abstract]
[Full Text]